Journal article
Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive disorder with poor prognosis. Response to treatment is infrequent and the use of immunosuppressive agents other than corticosteroids is the subject of ongoing discussion because of uncertain efficacy and side-effects. To determine the efficacy and safety of cyclophosphamide pulse therapy in IPF, this study retrospectively analysed 18 patients with progressive IPF who were treated with …
Authors
Kolb M; Kirschner J; Riedel W; Wirtz H; Schmidt M
Journal
European Respiratory Journal, Vol. 12, No. 6, pp. 1409–1414
Publisher
European Respiratory Society (ERS)
Publication Date
December 1, 1998
DOI
10.1183/09031936.98.12061409
ISSN
0903-1936